Meijun Zeng

Dr. Meijun Zeng

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
MZMeijun Zeng
Meijun Zeng
YLYang Li
Yang Li
JCJie Cheng
Jie Cheng
JWJingyu Wang
Jingyu Wang
QLQiyu Liu
Qiyu Liu
Prebiotic oligosaccharides have attracted significant interest in dermatology and skin health due to their ability to modulate the skin microbiome and microbiota–host interactions. This review offers a novel dual perspective, systematically examining the benefits of both oral intake and topical application of prebiotic oligosaccharides, including well-established prebiotics (e.g., human milk oligosaccharides, galacto- and fructo-oligosaccharides) and emerging prebiotic candidates (e.g., gluco-oligosaccharides, chitosan-oligosaccharides, agaro-oligosaccharides). First, cutting-edge synthetic processes for producing diverse oligosaccharides and their structural chemistry are introduced. Then, we discuss in vitro studies demonstrating their efficacy in promoting skin commensals, inhibiting pathogens, and conferring protective effects, such as antioxidant, anti-inflammatory, anti-melanogenic, and wound-healing properties. Furthermore, we emphasize in vivo animal studies and clinical trials revealing that prebiotic oligosaccharides, administered orally or topically, alleviate atopic dermatitis, enhance skin hydration, attenuate acne, and protect against photo-aging by modulating skin–gut microbiota and immune responses. Mechanistically, we integrate genetic and molecular insights to elucidate how oligosaccharides mediate these benefits, including gut–skin axis crosstalk, immune regulation, and microbial metabolite signaling. Finally, we highlight current commercial applications of oligosaccharides in cosmetic formulations while addressing scientific and practical challenges, such as structure–function relationships, clinical scalability, and regulatory considerations. This review bridges mechanistic understanding with practical applications, offering a comprehensive resource for advancing prebiotic oligosaccharides-based skincare therapies.


12 April 2025 in Bioresource Technology
Verified
Journal Article
Closed access
MZMeijun Zeng
Meijun Zeng
JOJee-Hwan Oh
Jee-Hwan Oh
JPJan-Peter van Pijkeren
Jan-Peter van Pijkeren
Xuejun PanXuejun Pan
Xuejun Pan

24 November 2025 in Foods
Verified
Journal Article
Open access
PDF file
MZMeijun Zeng
Meijun Zeng
YLYang Li
Yang Li
XWXiulian Wang
Xiulian Wang
TBTing Bai
Ting Bai
JCJie Cheng
Jie Cheng
WWWei Wang
Wei Wang
Chuanbai Rex (CR) and New Zealand white (NZ) rabbits are highly popular and widely produced for meat consumption in Sichuan, China. But comparative studies on nutritional and sensory qualities of meat from two breeds are still lacking. This study integrated lipidomic and volatilomic approaches to elucidate the breed-specific differences in the longissimus dorsi between CR and NZ (n = 5 per breed). Analysis of fatty acid composition revealed that CR had lower content of PUFA but with a more balanced n-6/n-3 PUFA ratio compared to NZ. LC-MS-based lipidomics identified 52 significantly different lipids between the two breeds, and CR had higher levels of phospholipids and sphingolipids, while NZ was richer in triglycerides and diglycerides. SPME-GC-MS analysis identified a total of 140 VOCs, including primarily aldehydes (>50%), alcohols (<20%), and hydrocarbons (<15%). CR contained unique aroma compounds such as acetoin and 2-(E)-heptenal, while NZ had more of nonanal and pentadecane. Pearson correlation analysis performed between differential lipid metabolites and characteristic VOCs showed that 22 lipid biomarkers were significantly correlated with seven key VOCs, suggesting breed-distinct pattern for flavor formation. Albeit a small sample size, this study provides preliminary insights into biochemical mechanisms determining rabbit meat quality and offers a scientific basis for developing premium rabbit meat products tailored to consumer preferences.

22 April 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SMSonali Mahapatra
Sonali Mahapatra
MZMeijun Zeng
Meijun Zeng
JPJan-Peter van Pijkeren
Jan-Peter van Pijkeren
MPManish Paul
Manish Paul
HTHrudayanath Thatoi
Hrudayanath Thatoi
Xuejun PanXuejun Pan
Xuejun Pan
Galactooligosaccharides (GOS) are widely recognized for their prebiotic properties and are often added to infant formulas with milk proteins. However, the effect of protein–oligosaccharide conjugates on probiotic survival and gastrointestinal (GI) persistence remains unclear. In this study, chemically synthesized GOS (sGOS) were produced from lactose, showing diverse glycosidic linkages and a degree of polymerization (DP) of 2–6. The prebiotic activity of sGOS was tested using Bifidobacterium bifidum ATCC 29521 and Levilactobacillus brevis ATCC 8287 in both in vitro and in vivo conditions. Both strains grew similarly after 24 h of incubation at 37°C in sGOS-supplemented media. However, in an in vivo mouse model, L. brevis showed improved GI survival and persistence with sGOS compared to B. bifidum. Interestingly, supplementing sGOS with goat milk, rather than cow milk, further enhanced GI persistence of L. brevis. In silico molecular docking and dynamics simulations revealed that goat milk β-casein and β-lactoglobulin had shorter binding durations with sGOS, allowing faster oligosaccharide release than cow milk proteins. These findings were supported by in vitro experiments using Maillard sGOS–protein conjugates, in which goat milk β-casein and β-lactoglobulin promoted faster sGOS release and promoted growth of L. brevis. Overall, the findings show that protein–oligosaccharide interactions greatly affect sGOS release and probiotic growth dynamics, highlighting the potential to design targeted protein–prebiotic conjugates to enhance the biological efficacy of chemically synthesized prebiotics in the gut.